Singapore braces for a leap of faith in its COVID-19 strategy japantimes.co.jp - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from japantimes.co.jp Daily Mail and Mail on Sunday newspapers.
Published: May 17, 2021
International award will fund preclinical study of CNM-Au8 nanocatalysis for the improvement of human health and lifespan in the contexts of aging and Alzheimer’s disease
Clene anticipates the expansion of disease indications for CNM-Au8 beyond amyotrophic lateral sclerosis, Parkinson’s disease, and multiple sclerosis
SALT LAKE CITY, May 17, 2021 (GLOBE NEWSWIRE)
Clene Inc. (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) today announced that its wholly owned subsidiary
Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company dedicated to the treatment of neurodegenerative disease using bioenergetic nanocatalysis, received a Healthy Longevity Catalyst Award from the U.S. National Academy of Medicine (NAM) to accelerate the preclinical development of CNM-Au8, a bioenergetic nanocatalyst, for treatment of neuronal aging-related deficits and Alzheimer’s disease. The Healthy Longevity Global Competition was founded in 2019
Operator
Good day, ladies and gentlemen, and welcome to the COMPASS Pathways first-quarter 2021 conference call. [Operator instructions]. As a reminder, this call is being recorded. I would now Like to introduce your host for today s conference, Stephen Schultz, senior vice president of investor relations.
You may begin.
Senior Vice President, Investor Relations
Thank you, operator, and welcome all of you, and thank you for joining us today for our first-quarter 2021 results call. Again, my name is Steve Schultz, senior vice president of investor relations at COMPASS Pathways. And today, I m joined by George Goldsmith, chairman and chief executive officer; and Piers Morgan, chief financial officer. George will begin today s call with a business update on our recent progress.
The Science Council was established by the WHO’s director-general Dr Tedros Gebresus, to directly advise the organisation about high-priority scientific issues affecting global health.
Sukham Blog – A monthly column focused on South Asian health and wellbeing.
When I see or hear the words Climate Change, I conjure up mental images of global warming, rising temperatures, melting ice caps, rising ocean levels, increasing CO2 and methane emissions, more frequent extreme weather events such as flooding, drought, and wildfires, and our planet Earth rapidly becoming less habitable for present and future generations. My mind does not turn immediately to the
ongoing impact on human health,
and the decreased quality of life that brings for people, something that is also happening today. Climate change is a big driver of poorer health and circumstance, resulting in hardship and loss of contentment – loss of